| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1349641 | Tetrahedron: Asymmetry | 2006 | 7 Pages |
Starting from (1S,4R) chiral ketone (+)-6, we developed a synthetic route to the synthesis of new chiral γ-amino alcohols (+)- and (−)-syn-2-amino-7-hydroxy norbornane derivatives with excellent yields and enantiomeric excesses (up to 99%). These compounds were tested as chiral catalysts in the enantioselective addition of diethylzinc to benzaldehyde presenting moderate results. The results obtained, compared with others previously reported, showed that the relative disposition of the amino and hydroxyl groups on C(2) and C(7) positions, play an important role in the catalytic activity.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
(−)-7,7-Dimethoxy-2-oximo-norbornaneC9H15NO3Ee >99%[α]D20=-35.5 (c 1.1, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,4R)
(−)-7,7-Dimethoxy-2-exo-amino-norbornaneC9H17NO2Ee >99%[α]D20=-18.0 (c 1.0, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R)
(−)-7,7-Dimethoxy-2-exo-trifluoroacetamide-norbornaneC11H16NO3F3Ee >99%[α]D20=-7.4 (c 1.2, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R)
(−)-2-exo-Piperidine-7-syn-hydroxy-norbornaneC12H21NOEe >99%[α]D20=-30.0 (c 1.0, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R,7S)
(+)-2-exo-Acetamido-7-syn-hydroxy-norbornaneC9H15NO2Ee >99%[α]D20=+5.4 (c 1.1, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R,7S)
(−)-2-exo-Ethylamino-7-syn-hydroxy-norbornaneC9H17NOEe >99%[α]D20=-20.0 (c1.0, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R,7S)
(+)-2-exo-Acetylethylamino-7-syn-acetate-norbornaneC13H21NO3Ee >99%[α]D20=+2.0 (c 1.1, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R,7S)
(−)-2-exo-N,N-Diethylamino-7-syn-hydroxy-norbornaneC11H21NOEe >99%[α]D20=-41.0 (c 1.1, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R,7S)
(−)-2-exo-N,N-Dimethylamino-7-syn-hydroxy-norbornaneC9H17NOEe >99%[α]D20=-25.0 (c 1.2, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R,7S)
(+)-2-exo-Trifluoroacetamide-7-one-norbornaneC9H10NO2F3Ee >99%[α]D20=+8.5 (c 2.0, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R)
(−)-2-exo-Trifluoroacetamide-7-syn-hydroxy-norbornaneC9H12NO2F3Ee >99%[α]D20=-3.6 (c 1.1, CHCl3)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R,7S)
(−)-2-exo-Amino-7-syn-hydroxy-norbornaneC7H13NOEe >99%[α]D20=-5.0 (c 1.2, CHCl3)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R,7S)
(+)-2-exo-Acetamido-7-syn-acetate-norbornaneC11H17NO3Ee >99%[α]D20=+22.3 (c 1.2, EtOAc)Source of chirality: enzymatic resolutionAbsolute configuration: (1S,2R,4R,7S)
